Adherence to disease-modifying therapies for multiple sclerosis and subsequent hospitalizations

Evans Charity; Marrie Ruth Ann; Zhu Feng; Leung Stella; Lu Xinya; Kingwell Elaine; Zhao Yinshan; Tremlett Helen

首页> 外文期刊>Pharmacoepidemiology and drug safety >Adherence to disease-modifying therapies for multiple sclerosis and subsequent hospitalizations

【24h】

Adherence to disease-modifying therapies for multiple sclerosis and subsequent hospitalizations

机译：依从疾病改性治疗多发性硬化和随后的住院治疗

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeThe aim of this study was to examine the association between optimal adherence to first-line disease-modifying therapies (DMT) for multiple sclerosis (MS) and hospitalizations.

机译：本研究的目的是检查对多发性硬化（MS）和住院治疗的最佳粘附到一线疾病改性治疗（DMT）之间的关联。

著录项

来源
《Pharmacoepidemiology and drug safety 》 |2017年第6期| 共10页
作者
Evans Charity; Marrie Ruth Ann; Zhu Feng; Leung Stella; Lu Xinya; Kingwell Elaine; Zhao Yinshan; Tremlett Helen;
展开▼
作者单位

Univ Saskatchewan Coll Pharm &

Nutr 104 Clin Pl Saskatoon SK S7N 5E5 Canada;

Univ Manitoba Dept Internal Med Winnipeg MB Canada;

Univ British Columbia Dept Med Neurol Vancouver BC Canada;

Univ Manitoba Dept Community Hlth Sci Winnipeg MB Canada;

Saskatchewan Hlth Qual Council Saskatoon SK Canada;

Univ British Columbia Dept Med Neurol Vancouver BC Canada;

Univ British Columbia Dept Med Neurol Vancouver BC Canada;

Univ British Columbia Dept Med Neurol Vancouver BC Canada;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学 ;
关键词
multiple sclerosis; adherence; hospitalizations; pharmacoepidemiology;

机译：多发性硬化;坚持;住院;药物缺氧化学;

相似文献

外文文献
中文文献
专利

1. Adherence to disease-modifying therapies for multiple sclerosis and subsequent hospitalizations [J] . Evans Charity, Marrie Ruth Ann, Zhu Feng, Pharmacoepidemiology and drug safety . 2017 ,第6期

机译：依从疾病改性治疗多发性硬化和随后的住院治疗
2. Adherence to disease-modifying therapies in spanish patients with relapsing multiple sclerosis: two-year interim results of the global adherence project. [J] . Arroyo E, Grau C, Ramo Tello C, European neurology . 2011 ,第2期

机译：在患有复发性多发性硬化症的西班牙患者中坚持采用改变疾病的疗法：全球坚持方案的两年中期结果。
3. With the availability of disease-modifying, immunomodulatory therapies (DMT) for multiple sclerosis (MS) and the first long-term studies, it became obvious that problems of compliance to complex treatment regimens under chronic conditions would also apply to these approaches. In a selective overview, problems and findings of adherence research are depicted. Based on a discussion of basic concepts, issues of operationally defining and measuring adherence are outlined. Descriptive findings on adhe [J] . Expert opinion on drug safety . 2009 ,第5期

机译：随着可用于多发性硬化症（MS）的疾病改良免疫调节疗法（DMT）的获得和首批长期研究的出现，很明显，在慢性条件下遵守复杂治疗方案的问题也将适用于这些方法。在选择性概述中，描述了依从性研究的问题和发现。在对基本概念进行讨论的基础上，概述了在操作上定义和衡量遵从性的问题。 adhe的描述性发现
4. Factors Affecting Adherence with Telerehabilitation in Patients with Multiple Sclerosis [C] . In Cheol JEONG, Jiazhen LIU Joseph FINKELSTEIN Information Technology and Communication in Health (Conference) . 2019

机译：影响多发性硬化症患者患者粘附性的因素
5. Aging and Disease-modifying Therapies in Multiple Sclerosis: Insights from Clinical Trials and Registries [D] . Zhang, Yinan. 2021

机译：多发性硬化症中的衰老和疾病改性疗法：临床试验和注册管理机构的见解
6. The Impact of Adherence to Disease-Modifying Therapies on Functional Outcomes in Veterans with Multiple Sclerosis [O] . Meheroz H Rabadi, Kimberly Just, Chao Xu 2021

机译：粘附对疾病修饰疗法对具有多发性硬化症的资深人士的功能结果的影响
7. Persistence and adherence to ocrelizumab compared with other disease-modifying therapies for multiple sclerosis in U.S. commercial claims data [O] . Natalie J Engmann, Danny Sheinson, Komal Bawa, 2021

机译：与美国商业索赔数据的多发性疾病修饰疗法相比，对ocrelizumab的持久性和粘附性

Adherence to disease-modifying therapies for multiple sclerosis and subsequent hospitalizations

摘要

著录项

相似文献

相关主题

期刊订阅